Attention‐deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: A systematic review and meta‐analysis

[1]  J. Ramos-Quiroga,et al.  The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study , 2023, Neuroscience & Biobehavioral Reviews.

[2]  B. D’Onofrio,et al.  Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder , 2022, JAMA network open.

[3]  M. Solmi,et al.  Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population‐based cohort study , 2022, World psychiatry : official journal of the World Psychiatric Association.

[4]  L. Snetselaar,et al.  Association between history of attention-deficit/hyperactivity disorder diagnosis and cardiovascular disease in U.S. adults. , 2022, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[5]  D. Llewellyn,et al.  Attention-deficit/hyperactivity disorder and ischemic stroke: A Mendelian randomization study , 2022, International journal of stroke : official journal of the International Stroke Society.

[6]  Henrik Larsson.  Transparent and complete reporting of confounding in observational research , 2022, JCPP Advances.

[7]  I. Bitter,et al.  Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors , 2022, World psychiatry : official journal of the World Psychiatric Association.

[8]  C. Correll,et al.  Temporal trends in associations between severe mental illness and risk of cardiovascular disease: A systematic review and meta-analysis , 2022, PLoS medicine.

[9]  C. Correll,et al.  Associations between mental and physical conditions in children and adolescents: An umbrella review , 2022, Neuroscience & Biobehavioral Reviews.

[10]  M. Solmi,et al.  Association between autism spectrum disorder and diabetes: systematic review and meta-analysis , 2022, Neuroscience & Biobehavioral Reviews.

[11]  A. Slaunwhite,et al.  Risk of cardiovascular diseases in relation to substance use disorders. , 2021, Drug and alcohol dependence.

[12]  A. Carvalho,et al.  Disparities in Screening and Treatment of Cardiovascular Diseases in Patients With Mental Disorders Across the World: Systematic Review and Meta-Analysis of 47 Observational Studies. , 2021, The American journal of psychiatry.

[13]  Chiadi E. Ndumele,et al.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2021, Circulation.

[14]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[15]  James R. Staley,et al.  The Effect of Attention Deficit/Hyperactivity Disorder on Physical Health Outcomes: A 2-Sample Mendelian Randomization Study , 2020, American journal of epidemiology.

[16]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[17]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[18]  B. D’Onofrio,et al.  Maternal pre-pregnancy overweight/obesity and the risk of attention-deficit/hyperactivity disorder in offspring: a systematic review, meta-analysis and quasi-experimental family-based study , 2020, International journal of epidemiology.

[19]  P. Imrey.  Limitations of Meta-analyses of Studies With High Heterogeneity. , 2020, JAMA network open.

[20]  M. Akmatov,et al.  Psychiatric and Nonpsychiatric Comorbidities Among Children With ADHD: An Exploratory Analysis of Nationwide Claims Data in Germany , 2021, Journal of attention disorders.

[21]  L. Qi,et al.  Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385 292 UK biobank participants. , 2019, European heart journal.

[22]  P. Lichtenstein,et al.  Stress related disorders and subsequent risk of life threatening infections: population based sibling controlled cohort study , 2019, BMJ.

[23]  S. Gnanavel,et al.  Attention deficit hyperactivity disorder and comorbidity: A review of literature , 2019, World journal of clinical cases.

[24]  D. Ussery,et al.  Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood , 2019, European heart journal.

[25]  D. Altman,et al.  COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology , 2019, PLoS medicine.

[26]  S. Dalsgaard,et al.  Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study , 2018, PloS one.

[27]  S. Samuel,et al.  Blood pressure in children with attention deficit/hyperactivity disorder. , 2018, Paediatrics & child health.

[28]  J. V. van Amsterdam,et al.  Causal Factors of Increased Smoking in ADHD: A Systematic Review , 2018, Substance use & misuse.

[29]  K. Klungsøyr,et al.  Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review , 2016, Journal of attention disorders.

[30]  B. Kiliç,et al.  Prevalence of obesity/hypertension in children and adolescents with ADHD and evaluation of total body composition , 2018 .

[31]  Paolo Santonastaso,et al.  Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls , 2017, World psychiatry : official journal of the World Psychiatric Association.

[32]  J. Denollet,et al.  Psychosocial perspectives in cardiovascular disease , 2017, European journal of preventive cardiology.

[33]  I. Fernández-Ruíz.  Immune system and cardiovascular disease , 2016, Nature Reviews Cardiology.

[34]  Jenny Tran,et al.  Meta-Analysis of Anxiety as a Risk Factor for Cardiovascular Disease. , 2016, The American journal of cardiology.

[35]  B. Penninx,et al.  Anxiety and new onset of cardiovascular disease: critical review and meta-analysis , 2016, British Journal of Psychiatry.

[36]  L. Rohde,et al.  Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis. , 2015, The American journal of psychiatry.

[37]  Bryan G. Cook,et al.  Obesity, Physical Activity, and Sedentary Behavior of Youth With Learning Disabilities and ADHD , 2015, Journal of learning disabilities.

[38]  D. Vancampfort,et al.  Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis , 2015, World psychiatry : official journal of the World Psychiatric Association.

[39]  A. Peters,et al.  Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium , 2015, BMJ : British Medical Journal.

[40]  Jan K. Buitelaar,et al.  Attention-deficit/hyperactivity disorder , 2015, Nature Reviews Disease Primers.

[41]  Min Li,et al.  Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. , 2014, International journal of cardiology.

[42]  S. Faraone,et al.  Attention-Deficit/Hyperactivity Disorder and Adverse Health Outcomes in Adults , 2014, The Journal of nervous and mental disease.

[43]  Peter Johansson,et al.  Depression and cardiovascular disease: a clinical review. , 2014, European heart journal.

[44]  A. Beekman,et al.  Attention‐Deficit/Hyperactivity Disorder, Physical Health, and Lifestyle in Older Adults , 2013, Journal of the American Geriatrics Society.

[45]  F. Castellanos,et al.  Does childhood attention-deficit/hyperactivity disorder predict risk-taking and medical illnesses in adulthood? , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[46]  H. Swartz,et al.  Cardiovascular disease and bipolar disorder: risk and clinical implications. , 2012, The Journal of clinical psychiatry.

[47]  Bruce H Fireman,et al.  ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. , 2011, JAMA.

[48]  C. Furberg,et al.  A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk , 2011, Circulation. Cardiovascular quality and outcomes.

[49]  F. J. McClernon,et al.  Association between Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms and obesity and hypertension in early adulthood: A population-based study , 2010, International Journal of Obesity.

[50]  Andy Wielgosz,et al.  Socioeconomic status and cardiovascular disease: risks and implications for care , 2009, Nature Reviews Cardiology.

[51]  J. Jokinen,et al.  HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. , 2009, Journal of affective disorders.

[52]  F. J. McClernon,et al.  ADHD and Smoking , 2008, Annals of the New York Academy of Sciences.

[53]  M. Davidson.  ADHD in adults: a review of the literature. , 2008, Journal of attention disorders.

[54]  H. Kuper,et al.  Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. , 2006, European heart journal.

[55]  M. Lokhandwala,et al.  Defective Renal Dopamine D1 Receptor Function Contributes to Hyperinsulinemia-Mediated Hypertension , 2006, Clinical and experimental hypertension.

[56]  C. Hennekens,et al.  Schizophrenia and increased risks of cardiovascular disease. , 2005, American heart journal.

[57]  T. Lewis,et al.  Psychosocial factors and cardiovascular diseases. , 2005, Annual review of public health.

[58]  J. Ambrose,et al.  The pathophysiology of cigarette smoking and cardiovascular disease: an update. , 2004, Journal of the American College of Cardiology.

[59]  W. Roberts,et al.  Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder , 2004, Molecular Psychiatry.

[60]  K. Matthews,et al.  Psychosocial factors and Risk of hypertension: The Coronary Artery Risk development in Young Adults (CARDIA) Study , 2003 .

[61]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[62]  R B D'Agostino,et al.  Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. , 1990, Statistics in medicine.